申请人:Novartis AG
公开号:US07879850B2
公开(公告)日:2011-02-01
The present invention provides compounds of the following structure;
A-Q-B—C-D
that are useful for treating conditions or disorders associated with DGAT1 activity in animals, particularly humans.
本发明提供以下结构的化合物; A-Q-B-C-D,它们对于治疗与动物中DGAT1活性相关的疾病或疾病特别是人类非常有用。